July 11, meeting of the Transparency Council.
The agenda is:
Preparation of a position on the legitimacy of granting consent for the reimbursement of the medicinal product Livmarli (maralixibat) in the indication: skin pruritus in the course of Alagille syndrome.
Preparation of opinions on draft health policy programs of local government units:
"Prevention of over...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
